InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,431.60
(
-0.04%
)
US TECH 100
19,168.00
(
0.52%
)
Dow Jones
38,589.16
(
-0.15%
)
Brent Oil
82.28
(
0.00%
)
Bitcoin
66,257.90
(
0.10%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

BiotechValues

Send PM Follow Ignore
Followers 355
Posts 9910
Boards Moderated 2
Alias Born 06/23/2007

BiotechValues

Re: None

Friday, 02/06/2015 8:55:15 AM

Friday, February 06, 2015 8:55:15 AM

Post# of 97239
$MEIP - new coverage just out with $10-$11 target

Wells Fargo initiated coverage on MEI Pharma (NASDAQ: MEIP) with an Outperform rating and a price target of $10-$11. Analyst Matthew Andrews sees the stock as undervalued based on pracinostat's potential in MDS and AML.

For an analyst ratings summary and ratings history on MEI Pharma click here. For more ratings news on MEI Pharma click here.

Shares of MEI Pharma closed at $3.95 yesterday.



http://www.streetinsider.com/New+Coverage/Wells+Fargo+Starts+MEI+Pharma+%28MEIP%29+at+Outperform/10236590.html

This could be the catalyst for a close above $4 today- which would help confirm the bottom (in my opinion). I'm on a $4 bid now in premarket and it hasn't filled yet.

IRP Disclosure

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up